alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF HANCOCK FABRICS, INC. FOR THE SIX MONTHS ENDED AUGUST 1,
1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-30-2000
<PERIOD-START>                             FEB-01-1999
<PERIOD-END>                               AUG-01-1999
<CASH>                                           7,777
<SECURITIES>                                         0
<RECEIVABLES>                                    1,455
<ALLOWANCES>                                         0
<INVENTORY>                                    138,640
<CURRENT-ASSETS>                               152,323
<PP&E>                                          26,240
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 194,815
<CURRENT-LIABILITIES>                           55,488
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           291
<OTHER-SE>                                      72,884
<TOTAL-LIABILITY-AND-EQUITY>                   194,815
<SALES>                                        179,213
<TOTAL-REVENUES>                               179,213
<CGS>                                           93,850
<TOTAL-COSTS>                                   93,850
<OTHER-EXPENSES>                                92,147
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,164
<INCOME-PRETAX>                                    539
<INCOME-TAX>                                       194
<INCOME-CONTINUING>                                345
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       345
<EPS-BASIC>                                        .02
<EPS-DILUTED>                                      .02


</TABLE>
[Federal Register Volume 75, Number 36 (Wednesday, February 24, 2010)]
[Notices]
[Page 8372]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3571]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel, HIV AIDS Training.
    Date: March 1, 2010.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852. (Telephone Conference 
Call.)
    Contact Person: Enid Light, PhD, Scientific Review Officer, 
Division of Extramural Activities, National Institute of Mental 
Health, NIH, Neuroscience Center, 6001 Executive Boulevard, Room 
6132, MSC 9608, Bethesda, MD 20852-9608, 301-443-0322, 
<a href="/cdn-cgi/l/email-protection#d6b3babfb1bea296bbb7bfbaf8b8bfbef8b1b9a0"><span class="__cf_email__" data-cfemail="1a7f76737d726e5a777b737634747372347d756c">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.281, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training, National Institutes of Health, HHS)

    Dated: February 16, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-3571 Filed 2-23-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit 32**

 

**CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED**

**PURSUANTTO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

The certifications set forthbelow are hereby submitted to the Securities and Exchange Commission pursuantto, and solely for the purpose of complying with, Section 1350 of Chapter63 of Title 18 of the United States Code in connection with the filing on thedate hereof with the Securities and Exchange Commission of the Quarterly Reporton Form 10-Q of the Company for the quarter ended September 30,2009.

 

Each of theundersigned hereby certifies in his capacity as an officer of CitizensBancshares Corporation and subsidiary (the “Company”) that, to his knowledge onthe date of this certification, the Quarterly Report of the Company on Form 10-Qfor the period ended September 30, 2009 fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934 and that the information contained in such report fairlypresents, in all material respects, the financial condition of the Company atthe end of such period and the results of operations of the Company for suchperiod.

 

 
| Date:    November 13, 2009 | By:                                   | /s/ James E. Young |
|-------------------------------------------|---------------------------------------|--------------------|
|                                      | James E. Young                        |
|                                      | President and Chief Executive Officer |
|                                      |                                  |               |
|                                      |                                  |               |
| Date:    November 13, 2009 | By:                                   | /s/ Cynthia N. Day |
|                                      | Cynthia N. Day                        |
|                                      | Senior Executive Vice President and   |
|                                      | Chief Operating Officer               |
|                                      |                                  |               |
|                                      |                                  |               |
| Date:    November 13, 2009 | By:                                   | /s/ Samuel J. Cox  |
|                                      | Samuel J. Cox                         |
|                                      | Executive Vice President and          |
|                                      | Chief Financial Officer               |

 

----
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 240 Engrossed in House (EH)]

<DOC>
H. Res. 240

                In the House of Representatives, U. S.,

                                                         April 4, 2017.
    Resolved, That upon adoption of this resolution it shall be in order to 
consider in the House the bill (H.R. 1343) to direct the Securities and Exchange 
Commission to revise its rules so as to increase the threshold amount for 
requiring issuers to provide certain disclosures relating to compensatory 
benefit plans. All points of order against consideration of the bill are waived. 
An amendment in the nature of a substitute consisting of the text of Rules 
Committee Print 115-11 shall be considered as adopted. The bill, as amended, 
shall be considered as read. All points of order against provisions in the bill, 
as amended, are waived. The previous question shall be considered as ordered on 
the bill, as amended, and on any further amendment thereto, to final passage 
without intervening motion except: (1) one hour of debate equally divided and 
controlled by the chair and ranking minority member of the Committee on 
Financial Services; (2) the further amendment printed in the report of the 
Committee on Rules accompanying this resolution, if offered by the Member 
designated in the report, which shall be in order without intervention of any 
point of order, shall be considered as read, shall be separately debatable for 
the time specified in the report equally divided and controlled by the proponent 
and an opponent, and shall not be subject to a demand for a division of the 
question; and (3) one motion to recommit with or without instructions.
            Attest:

                                                                          Clerk.
```
[No. 20158-5-II.

Division Two.

December 5, 1997.]

#### *In the Matter of the Marriage of*Lisa Anne Elofson, *Respondent,*and Arnold Robert Elofson, *Petitioner.*

Appeal from a judgment of the Superior Court for Clallam County, No. 86-3-00362-9, Kenneth D. Williams, J., entered November 3, 1995. *Reversed*by unpublished opinion per Morgan, J., concurred in by Seinfeld and Armstrong, JJ.
##### 



EXHIBIT 31.1 CERTIFICATION PURSUANT TO
EXCHANGE ACT RULE 13a-14 I, Gordon Ellis, President and Chief Executive Officer, certify that: (1) I have reviewed this Form 10-QSB of International Absorbents Inc.; (2) Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report; (3) Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the small
business issuer as of, and for, the periods presented in this report; (4) The small business issuers other certifying officer(s) and I are
responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small
business issuer and have: (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the small business issuer,
including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report
is being prepared; (b) Evaluated the effectiveness of the small business issuers
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on
such evaluation; and (c) Disclosed in this report any change in the small business
issuers internal control over financial reporting that occurred during
the small business issuers most recent fiscal quarter (the small business
issuers fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the
small business issuers internal control over financial reporting; and (5) The small business issuers other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the small business issuers auditors and the audit
committee of the small business issuers board of directors (or persons
performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the small business issuers ability
to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the small business issuers
internal control over financial reporting. Date: June 9, 2004 /s/ Gordon Ellis  
 23
<PAGE>   1

                                  EXHIBIT 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


        We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (No. 33-97556 and No. 333-43685) of Data Dimensions, Inc.
of our report dated February 17, 1998, appearing on page F-2 of Data Dimensions,
Inc. Annual Report on Form 10-KSB for the year ended December 31, 1997.

BDO SEIDMAN, LLP

Seattle, Washington
March 27, 1998
[No. 39794-0-I.

Division One.

November 3, 1997.]

#### The State of Washington, *Respondent,*v. Rasheed H. Shabazz, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 96-8-05506-1, Richard A. Jones, J., entered October 30, 1996. *Affirmed*by unpublished per curiam opinion.
Exhibit 99.1

                         AMCOL INTERNATIONAL CORPORATION

                   Certification of Periodic Financial Report
                       Pursuant to 18 U.S.C. Section 1350

      Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, the undersigned officer of AMCOL International
Corporation (the "Company") certifies that the Quarterly Report on Form 10-Q of
the Company for the quarter ended March 31, 2003 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and information contained in that Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Dated:   May 13, 2003                          /s/ Lawrence E. Washow
                                               ----------------------
                                               Lawrence E. Washow
                                               Chief Executive Officer

      A signed original of this written statement required by Section 906 has
been provided to AMCOL International Corporation and will be retained by AMCOL
International Corporation and furnished to the Securities and Exchange
Commission or it's staff upon request.


                                       20
<PAGE>

                                                                    Exhibit 99.1

                         AMCOL INTERNATIONAL CORPORATION

                   Certification of Periodic Financial Report
                       Pursuant to 18 U.S.C. Section 1350

      Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, the undersigned officer of AMCOL International
Corporation (the "Company") certifies that the Quarterly Report on Form 10-Q of
the Company for the quarter ended March 31, 2003 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and information contained in that Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Dated:   May 13, 2003                            /s/  Gary L. Castagna
                                                 ---------------------
                                                 Gary L. Castagna
                                                 Chief Financial Officer

      A signed original of this written statement required by Section 906 has
been provided to AMCOL International Corporation and will be retained by AMCOL
International Corporation and furnished to the Securities and Exchange
Commission or it's staff upon request.


                                       21
<PAGE>
                                                                 Exhibit 10.19.1

                             FIRST AMENDMENT TO THE

                        SHORT TERM INVESTMENT AGREEMENT

This FIRST AMENDMENT ("Amendment") is dated as of January 1, 2002, by and
between WFS FINANCIAL INC, a California corporation ("WFS"), and WESTERN
FINANCIAL BANK, a federally chartered savings bank fka Western Financial Savings
Bank. F.S.B. (the "Bank"), and amends the SHORT TERM INVESTMENT AGREEMENT
("Agreement") entered into by the parties on January 1, 1996, pursuant to
certain short-term investment services provided by the Bank to WFS.

                                    RECITALS

The Agreement is being amended to reflect a change in the interest rate payable
by the Bank to WFS pursuant to the terms and conditions in the Agreement.

                                   AGREEMENT

In consideration of the mutual promises set forth herein, and in reliance upon
the recitals set forth above, the parties agree as follows:

1.   The third sentence in Clause 3 of the Agreement is hereby changed and
     replaced by the following sentences:

     "Interest shall be paid at a rate equal to 1-month LIBOR, and shall accrue
     daily. The LIBOR rate used shall be the LIBOR rate in effect on the last
     day of the prior month."

2.   Except as specifically amended herein, all terms of the Agreement shall
     remain in full force and effect.

Wherefore, the undersigned have executed this Amendment on the date set forth
below to be effective as of the date first set forth above.

WFS FINANCIAL INC                            WESTERN FINANCIAL BANK

/s/ Thomas A. Wolfe                          /s/ Lee A. Whatcott
------------------------------               ---------------------------------
Thomas A. Wolfe, President and               Lee A. Whatcott,
Chief Operating Officer                      Senior Executive Vice President
                                             and Chief Financial Officer
# Evaluation of Well Records and Geophysical Logs for Determining the Presence of Freshwater, Saltwater, and Gas above the Marcellus Shale,

South - Central New York John H. Williams New York Water Science Center Troy, New YorkGlacial - drift aquifers

7 - county study area Marcellus Shale outcrop



### Study Area in South - Central New York

## National Water Information System

of the U. S. Geological Survey • Records of 4,000 wells • Most inventoried during 1960s and 1970s • Glacial valley-fill aquifer investigations in the Susquehanna River Basin • Public - and domestic - supply wells



## Water Well Permitting Program of the New York State Department of Environmental Conservation • Records of 8,000 wells drilled since 2000 • Mostly domestic - supply wells, many in the bedrock uplands 

## Empire State Oil and Gas Information System of the New York State Museum Reservoir Group • Records of 600 gas wells (density decreases to the east and north) • Many gas -well records contain little information above Marcellus • Geophysical logs from 150 gas wells in LAS format • Geophysical logs collected after installation of steel surface casing • Few focused resistivity, induction, and temperature logs above the Marcellus • No fluid resistivity or fluid conductivity logs

### Water Wells in USGS Database South - Central New York

### Depth of Water Wells in USGS Database South - Central New York

### Water Wells that Penetrated Saltwater in South - Central New York

Modified from Williams ( 2011)

### Water Wells that Penetrated Saltwater in North - Central Pennsylvania

Williams and others (1998)344 588 7,800

40

10 13 2.1 0.2 36

NS 30

3.1 

### Water Quality of Typical Freshwater and Salty Water Wells in Upper Devonian Bedrock

Salty water wells (Williams and others, 1998) 3 4,600

304 Tioga County, PA

### Water Wells in NYSDEC Database South - Central New York

### Depth of Water Wells in USGS and NYSDEC Databases South - Central New YorkModified from Williams ( 2011)



### Gas Wells that Penetrated Freshwater South - Central New York

### Depth of Freshwater Zones Penetrated by Gas Wells South - Central New YorkModified from Williams ( 2011)



### Wells that Penetrated Gas above the Marcellus Shale

South Central New York

### Freshwater and Gas in Close Vertical Proximity

### Gas Show and Temperature Log

Surface casing

Gas

## Considerations for Future Gas -Well Drilling

• Consistent and complete reporting of freshwater, saltwater, and gas

• Field measurement of specific conductance of water produced during drilling

## Considerations for Future Gas -Well Logging

• Two - phase open - hole logging program including collection of caliper, induction, fluid resistivity, and temperature logs; in the first phase, the uppermost part of the hole logged prior to the installation of steel surface casing

## Considerations for Future Database Development

• Compilation and integration of information from gas wells and from water wells that are inventoried and water- quality sampled during gas development and ongoing county- and basin -wide programs
#### McFarland *v.*The State.

[No. 19,238.

Filed April 6, 1900.]

Criminal *Law.*— Rape.—Evidence.—Where in a conviction for rape the evidence failed to show the name of the person upon whom the rape was alleged to have been committed the, judgment will be reversed.

From the Hamilton Circuit Court.

*Reversed.*

*8. D. 8tuart*and C. *Q. Reagan,*for appellant.

*W. L. Taylor,*Attorney-General, *Merrill Moores, C. C. Hadley*and *J. F. Carver,*for State.

Baker, J.

Appellant was convicted of rape. The affidavit and information name Laura Yan Buskirk as .the *443alleged victim. In the evidence, the only name proved was Lillie, — nothing more. The name was an essential element in the legal description of the offense. *McLaughlin*v. *State, 52*Ind. 279; *McLaughlin*v. *State, 52*Ind. 476; *Black*v. *State,*57 Ind. 109; *Mitchell*v. *State,*63 Ind. 276. for failure of proof, the judgment is reversed, with directions to sustain the motion for a new trial.
§ 208.1 Scope and purpose. ( a ) This part sets forth requirements for patient labeling for human prescription drug products, including biological products, that the Food and Drug Administration (FDA) determines pose a serious and significant public health concern requiring distribution of FDA-approved patient information. It applies primarily to human prescription drug products used on an outpatient basis without direct supervision by a health professional. This part shall apply to new prescriptions and refill prescriptions.
( b ) The purpose of patient labeling for human prescription drug products required under this part is to provide information when the FDA determines in writing that it is necessary to patients' safe and effective use of drug products.
( c ) Patient labeling will be required if the FDA determines that one or more of the following circumstances exists: ( 1 ) The drug product is one for which patient labeling could help prevent serious adverse effects.
( 2 ) The drug product is one that has serious risk(s) (relative to benefits) of which patients should be made aware because information concerning the risk(s) could affect patients' decision to use, or to continue to use, the product.
( 3 ) The drug product is important to health and patient adherence to directions for use is crucial to the drug's effectiveness.
###### Editorial Note on Part 172

#### Editorial Note:

Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

#### § 172.520 Cocoa with dioctyl sodium sulfosuccinate for manufacturing.

The food additive “cocoa with dioctyl sodium sulfosuccinate for manufacturing,” conforming to § 163.117 of this chapter and § 172.810, is used or intended for use as a flavoring substance in dry beverage mixes whereby the amount of dioctyl sodium sulfosuccinate does not exceed 75 parts per million of the finished beverage. The labeling of the dry beverage mix shall bear adequate directions to assure use in compliance with this section.